Health Care Deal Volume Stays Strong in Q1:2018, as Deal Value Rises, According to

Thursday, April 19, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Health care merger and acquisition activity in the first quarter of 2018 kept pace with the previous quarter in 2017.

NORWALK, Conn., April 19, 2018 /PRNewswire-PRWeb/ -- Health care merger and acquisition activity in the first quarter

of 2018 kept pace with the previous quarter in 2017. Compared with the fourth quarter of 2017, deal volume increased 1%, to 386 transactions. However, deal volume was down 12% compared with the same quarter the year before. Combined spending in the first quarter reached $112.9 billion, a decrease of 2% compared with the nearly $115.0 billion spent in the previous quarter, according to Thanks to the announcement of a multi-billion-dollar deal in Q1:18, deal value rose 90% compared with $59.6 billion spent in Q1:17.

Health care services represented 61% of the first quarter's transaction total, lower than the 62% share reported in the previous quarter and the year-ago quarter (both 63%). The slight decrease is due to starkly lower M&A activity in four of the services sectors, Laboratories, MRI & Dialysis (-53%), Managed Care (-40%), Other Services (-25%) and Behavioral Health Care (-15%), versus the previous quarter. Those losses were offset by a 50% increase in deal activity in the Home Health & Hospice sector, and modest increases in the Hospital, Physician Medical Groups and Rehabilitation sectors (all +9%). The Long-Term Care sector, which has seen a marked decrease in deal making in some sub-sectors, managed to increase 8% in Q1:18.

On the technology side, transaction growth was strong in the Biotechnology (+20%) and eHealth (+53%) sectors, compared with the previous quarter. However, M&A activity in both sectors was lower than the year-ago quarter, down 6% in both sectors. The Medical Devices and Pharmaceuticals sectors were markedly lower compared with the fourth quarter, down 25% and 24%, respectively.

"The first quarter was dominated by Cigna's announced acquisition of Express Scripts, for $67 billion. That followed CVS Health's $77 billion deal for Aetna, announced in the fourth quarter of 2017," said Lisa E. Phillips, editor of " Although Cigna's deal certainly increased spending in the first quarter, the deal isn't the game-changer that we're expecting if the CVS/Aetna merger goes forward."

The real disruption in 2018 could come from the talks between retail giant Walmart and Humana, reported in March 2018 by The Wall Street Journal. "If that deal closes, U.S. healthcare becomes a retail product, and delivery of non-urgent care moves from the emergency room to Main Street," Phillips added.

For more information on the investment research source, or for a membership to any of Irving Levin Associates' services, please call 800-248-1668. Irving Levin Associates, Inc., established in 1948, is headquartered in Norwalk, Connecticut and is online at This privately held corporation publishes annual and quarterly research reports, monthly and weekly newsletters, and maintains merger and acquisition databases on the health care and senior housing markets. If you would like to receive future releases, please email pressreleases(at)levinassociates(dot)com.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store